FDA Import Refusal 799-2996708-9/11/1 — Sanofi Aventis Us Inc

Sanofi Aventis Us Inc — FEI 3011852213

The FDA refused shipment 799-2996708-9/11/1 from Sanofi Aventis Us Inc (United States) on Sep 19, 2019. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.

Refusal details

Date
Sep 19, 2019
Country
United States
Product Category
Drugs and Biologics
Product Code
61PDA31 GLIMEPIRIDE (ANTI-DIABETIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.